Drug Profile
Zika virus vaccine - Sanofi Pasteur
Alternative Names: Zika virus purified inactivated vaccine - Sanofi; ZIKV vaccine - Sanofi; ZPIV - SanofiLatest Information Update: 08 Apr 2022
Price :
$50
*
At a glance
- Originator Sanofi Pasteur
- Developer National Institute of Allergy and Infectious Diseases; Sanofi Pasteur; Walter Reed Army Institute of Research
- Class Viral vaccines; Zika virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Zika virus infection
Most Recent Events
- 30 Oct 2018 National Institute of Allergy and Infectious Diseases completes a phase-I clinical trials in Zika virus infection (Prevention) in USA (IM) (NCT02963909)
- 04 Jun 2018 Beth Israel Deaconess Medical Center completes the Z001 phase I trial for Zika virus infection (Prevention) in USA (NCT02937233)
- 05 Dec 2017 Adverse events data from three phase I trials in Zika virus infection released by Walter Reed Army Institute of Research